Research & University News

New collaboration among Big Pharma companies

Location

United States

Three large pharmaceutical companies have set up a new not-for-profit company to conduct research into the most commonly-diagnosed cancers in Asia. The initial focus of the research will be on lung and gastric cancers.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

UK cancer charity in major alliance with AstraZeneca

Location

United Kingdom

Cancer Research Technology (CRT) has entered into a three-year drug discovery and development alliance with AstraZeneca Plc that is expected to lead to the identification of new small molecule drugs targeting changes in a cell’s metabolism.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Oral formulations of MS drugs said to be effective

Location

Switzerland

Oral formulations of two investigational drugs for multiple sclerosis have been shown to be effective in reducing the rate of disease relapse, according to three papers in the New England Journal of Medicine. The drugs are oral fingolimod and oral cladribine.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Evotec to tackle Huntington’s disease

Location

Germany

Evotec AG has reinforced its position in drug discovery with a new agreement to identify potential treatments for Huntington’s disease. The agreement comes at a time when the Germany-based company is narrowing its strategic focus after setbacks more than a year ago with two clinical-stage products

Full text available to subscribers only. Click here for information on subscribing to MedNous.

GSK to make 13,500 malaria compounds freely available

Location

United Kingdom

GlaxoSmithKline is to make 13,500 potential malaria compounds freely available to researchers from around the world in a bid to stimulate work on medicines for the developing world. It is also allocating $8 million to a new research foundation.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Novel technology transfer deal reported for antibody candidates

Location

Germany

A novel licensing deal among two German universities and the UK Medical Research Council’s commercialization arm is expected to lead to the development of a potential new therapy for rheumatoid arthritis and multiple sclerosis.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

First complete genomic analysis of lung cancer and melanoma announced

Location

United Kingdom

Researchers at the Wellcome Trust Sanger Institute in the UK have completed the first complete genomic analysis of lung cancer and melanoma, revealing all of the genetic mutations that are present in the two diseases.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Cancer Research UK reports on new radioactive cancer therapy

Location

United Kingdom

Cancer Research UK has reported that an experimental radioactive cancer therapy showed clinical benefit in a Phase 1 study of patients with Hodgkin’s lymphoma. The study was published in the journal Clinical Cancer Research on 15 December 2009.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Embryonic stems cells used to reconstitute human skin tissue

Location

France

Researchers from France and Spain have reported being able to produce human skin tissue in mice from human embryonic stem cells, a finding that could have application for patients with burn injuries. The preclinical study was reported in The Lancet.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Genetic link to obesity reported

Location

United Kingdom

Scientists in Cambridge, UK have reported that children who are severely obese have a common genetic mutation that appears to predispose them to the disease from an early age. The findings were published on 6 December 2009 in the journal, Nature.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content